How much does Medicaid spend on GLP-1 drugs in each state?

How much does Medicaid spend on GLP-1 drugs in each state?

Pharmacies were reimbursed at least $12.05 billion for GLP-1 drugs paid through Medicaid nationwide in 2025, across at least 11,261,770 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 81 rows of 513, so these figures are floors. The largest published state amounts in 2025 were California (at least $3.46 billion), Pennsylvania (at least $951.4 million), New York (at least $941.2 million), Michigan (at least $681.1 million) and North Carolina (at least $590.0 million). States with suppressed rows show only a floor and cannot be ranked against the others.

Every state, 2025

Sorted by total amount reimbursed. Each state links to its page, with every year from 2020 and each quarter.

Alabamaat least $72,334,685at least 71,83157 of 171
Alaskaat least $22,152,586at least 23,249102 of 202
Arizonaat least $98,252,621at least 93,64576 of 215
Arkansasat least $18,871,001at least 24,039111 of 279
Californiaat least $3,462,543,976at least 3,090,45250 of 319
Coloradoat least $127,199,098at least 123,01269 of 284
Connecticutat least $202,814,053at least 174,55321 of 141
Delawareat least $21,354,918at least 55,674104 of 218
District of Columbiaat least $28,122,591at least 27,754115 of 265
Floridaat least $128,079,710at least 133,48285 of 252
Georgiaat least $52,526,193at least 59,45676 of 283
Hawaiiat least $33,872,236at least 30,47849 of 144
Idahoat least $46,072,822at least 45,95442 of 156
Illinoisat least $305,552,662at least 288,52265 of 287
Indianaat least $204,764,005at least 190,16282 of 297
Iowaat least $87,363,112at least 88,51883 of 227
Kansasat least $53,573,102at least 50,90336 of 161
Kentuckyat least $238,314,570at least 274,53897 of 292
Louisianaat least $230,946,267at least 230,35963 of 229
Maineat least $40,616,132at least 41,65541 of 162
Marylandat least $142,812,988at least 148,648119 of 308
Massachusettsat least $404,519,821at least 399,03098 of 345
Michiganat least $681,063,451at least 608,028102 of 366
Minnesotaat least $255,696,545at least 230,59479 of 337
Mississippiat least $70,718,721at least 61,646115 of 285
Missouriat least $284,863,196at least 285,10547 of 165
Montanaat least $22,195,107at least 22,71947 of 139
Nebraskaat least $36,117,422at least 37,33548 of 144
Nevadaat least $81,868,395at least 70,93984 of 279
New Hampshireat least $37,487,064at least 34,65267 of 190
New Jerseyat least $151,445,199at least 165,667135 of 289
New Mexicoat least $64,499,377at least 64,832113 of 255
New Yorkat least $941,187,086at least 816,61667 of 245
North Carolinaat least $589,996,654at least 484,71294 of 338
North Dakotaat least $3,605,150at least 5,85257 of 100
Ohioat least $406,954,834at least 425,347115 of 357
Oklahomaat least $83,573,455at least 82,36566 of 264
Oregonat least $67,351,293at least 72,793106 of 290
Pennsylvaniaat least $951,405,819at least 844,001107 of 366
Puerto Ricoat least $51,822,634at least 48,73237 of 148
Rhode Islandat least $48,888,755at least 46,69181 of 250
South Carolinaat least $64,945,523at least 65,093105 of 279
South Dakotaat least $15,709,847at least 15,60240 of 113
Tennesseeat least $144,104,065at least 136,02345 of 189
Texasat least $179,016,062at least 172,353114 of 244
Utahat least $28,648,950at least 28,00797 of 247
Vermontat least $18,537,316at least 17,16338 of 133
Virginiaat least $230,109,559at least 227,621123 of 329
Washingtonat least $82,653,211at least 111,20298 of 281
West Virginiaat least $91,584,548at least 94,99953 of 149
Wisconsinat least $327,847,844at least 302,67218 of 168
Wyomingat least $2,244,963at least 2,31576 of 140

A state marked “at least” or “Suppressed” has rows CMS withheld, so its full amount is unknown and it cannot be ranked against other states; its place in this order reflects only the rows CMS published.

Nationwide, by year and ingredient

2020at least $283,898,491No data$567,508,684at least $596,408,518at least $193,861,115at least $671,511$7,761,540$5,421,897at least $1,655,531,756
2021at least $554,820,690No data$680,639,494at least $1,188,068,204at least $134,241,933at least $1,080,158$9,594,531$4,796,567at least $2,573,241,576
2022at least $1,149,248,802at least $34,060,250$722,777,322$2,153,391,817at least $98,166,895at least $359,908$12,192,603$4,138,825at least $4,174,336,421
2023at least $2,911,348,586at least $439,944,750$722,050,605$2,839,397,030at least $82,702,773at least $11,027$9,422,199$3,295,077at least $7,008,172,046
2024at least $5,107,538,873at least $1,205,743,835$294,458,438$2,163,300,920at least $66,016,586No data$6,859,607$2,280,203at least $8,846,198,462
2025at least $6,613,338,249at least $3,323,545,465$145,922,324$1,948,292,919at least $15,363,655No data$4,455,588$1,460,353at least $12,052,378,553
2026 (Q1)at least $1,251,443,577at least $911,460,172at least $24,183,285$391,170,412at least $137,347No data$762,625$275,378at least $2,579,432,797

The amounts are CMS’s “Total Amount Reimbursed” field. CMS’s data dictionary for State Drug Utilization Data says of it:

“This total is not reduced or affected by Medicaid rebates paid to the state. This amount represents both the Federal and State Reimbursement and is inclusive of dispensing fees.”

Its prescription count is “The number of prescriptions reimbursed (by the Medicaid Program ONLY) to pharmacists for the (11-digit NDC) drug for the period covered.”

CMS suppresses some rows (its “Suppression Used” field is true and the counts and amounts are left blank). Here a suppressed row is never counted as zero: a figure that includes suppressed rows is shown as “at least” the sum of the rows CMS did publish, and a figure where every row is suppressed is shown as “Suppressed.” The “Rows suppressed” column gives the count. Where many rows are suppressed, the published sum can be well below the full amount, so floors for different states are not directly comparable.

State totals reflect how many people each program covers and which drugs it pays for; this page does not compare state coverage rules. Fee-for-service and managed care rows are added together.

Common questions

How much did Texas Medicaid spend on GLP-1 drugs in 2025?

Pharmacies were reimbursed at least $179.0 million for GLP-1 drugs paid through Texas Medicaid in 2025, across at least 172,353 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 114 rows of 244, so these figures are floors.

How much did California Medicaid spend on GLP-1 drugs in 2025?

Pharmacies were reimbursed at least $3.46 billion for GLP-1 drugs paid through California Medicaid in 2025, across at least 3,090,452 prescriptions, according to CMS’s State Drug Utilization Data. That is the total amount reimbursed, federal and state shares together, before the rebates manufacturers pay states. CMS suppressed 50 rows of 319, so these figures are floors.

Why are some state figures marked “at least” or “Suppressed”?

CMS suppresses some rows and leaves their amounts blank. This index never counts a suppressed row as zero: totals that include one are floors, and totals with only suppressed rows are shown as suppressed.

Medicare figures: Medicare and Medicaid spending on GLP-1 drugs.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.